SNIPR Biome

Snipr Biome is a synthetic biology company using CRISPR to make products for the microbiome that is headquartered in Copenhagen, Denmark, and was founded in 2017 by Christian Grondahl, Morten O.A. Sommer, and Jasper Clube. Snipr Biome uses CRISPR systems the company calls CRISPR-Guided Vectors to target and kill specific bacterial species living within the human microbiome while leaving all other strands of bacteria intact.

Snipr Biome has been granted a total of five patents (as of September 2019); they are: US9701964, US10195273, US10300138, US10300139, and US10363308.

On March 11, 2019, Snipr Biome completed its series A funding round with $50 million in funding from Lundbeckfonden Emerge (lead investor), LSP (lead investor), North-East Family Office, and Wellington Partners. The company plans on using its series A funding to further develop its CRISPR technology platform and fund its first clinical trials. The cofounder and CEO of Snipr Biome, Dr. Christian Grondahl, made the following statement to reporters regarding his company's series A funding:

We have the potential to develop valuable therapeutics within multiple important disease areas. We will focus initially on precision medicines for difficult-to-treat infections and precision microbiome modulation in auto-immunity and cancer. We are utilizing the bacteria’s CRISPR/Cas immune system to selectively kill target bacteria based on specific DNA fingerprints. We are thrilled to have obtained this massive and transformational funding and backing from absolute leading European VCs and investors in Lundbeckfonden Emerge, Life Science Partners, North-East Family Office, and Wellington Partners.